Clinical Guide: Skene’s Gland Abscess (Paraurethral Duct Abscess)

1. Comprehensive Introduction & Overview

Skene’s glands, also known as the paraurethral glands, are homologous to the prostate gland in males. Located on the anterior wall of the vagina, around the lower end of the urethra, these glands play a critical role in the female urogenital anatomy. While they are often overlooked in routine clinical practice, their clinical significance emerges prominently when they become obstructed or infected.

A Skene’s Gland Abscess represents a localized collection of purulent material within these glands. It is a rare but painful condition that requires prompt clinical intervention. Because of their proximity to the urethra and the bladder neck, abscesses in this region can mimic other urological or gynecological pathologies, often leading to diagnostic delays. This guide provides an exhaustive clinical overview for medical professionals to identify, manage, and treat this condition effectively.

2. Technical Specifications & Mechanisms

Etiology and Pathophysiology

The Skene’s glands are lined with pseudostratified columnar epithelium. Their ducts open into the vestibule, immediately lateral to the external urethral meatus. Pathophysiology typically follows a predictable sequence:

1. Ductal Obstruction: The primary trigger is the obstruction of the ductal opening. This can be caused by epithelial desquamation, mucus plugging, or trauma.
2. Bacterial Colonization: Once the duct is obstructed, the stagnant secretions become a nidus for bacterial growth. Common pathogens include:
   • Escherichia coli (most common)
   • Neisseria gonorrhoeae
   • Staphylococcus aureus
   • Chlamydia trachomatis
   • Mixed anaerobic flora
3. Abscess Formation: The inflammatory response leads to the accumulation of neutrophils and pus, resulting in the expansion of the gland. Because the gland is confined by the periurethral tissues, the pressure causes significant localized pain.

Clinical Staging/Grading

While there is no universally standardized staging system for Skene’s gland abscesses, clinicians often categorize them by severity to determine the treatment approach:

3. Clinical Indications & Standard Presentation

Presentation

Patients typically present in the 3rd to 5th decade of life. The clinical hallmark is a painful, tender, cystic mass located at the 4 or 8 o’clock position relative to the external urethral meatus.

• Symptoms:
  • Dysuria (often severe).
  • Localized vulvar pain, exacerbated by walking or sitting.
  • Dyspareunia.
  • Urinary retention (if the abscess is large enough to compress the urethra).
  • Post-void dribbling.
• Physical Exam Findings:
  • Visible, erythematous, tender mass adjacent to the urethral meatus.
  • Fluctuance on gentle palpation.
  • Purulent discharge upon milking the gland (if the duct is partially patent).

Diagnostic Workup

Diagnosis is primarily clinical, but imaging is utilized for complicated cases or to rule out urethral diverticula.

1. Physical Examination: Careful inspection of the periurethral area is essential.
2. Transvaginal/Translabial Ultrasound: The gold standard for imaging. It can differentiate an abscess from a urethral diverticulum (which is often larger and communicates directly with the urethra).
3. MRI Pelvis: Indicated if the diagnosis is unclear or if a complex urethral diverticulum is suspected.
4. Microbiological Culture: Swabbing the discharge or the abscess cavity contents for aerobic/anaerobic culture and sensitivity.

4. Risks, Side Effects, and Complications

Potential Complications

Failure to treat or misdiagnosis of a Skene’s gland abscess can lead to significant morbidity:

• Urethrovaginal Fistula: Chronic inflammation or improper surgical drainage can erode the urethral wall, leading to a permanent fistula and subsequent stress urinary incontinence.
• Recurrence: Incomplete drainage or persistent ductal obstruction leads to a high rate of recurrence.
• Urethral Stricture: Secondary to chronic inflammation and subsequent scarring.
• Sepsis: Rare, but possible in immunocompromised patients if the infection spreads to the surrounding connective tissue (necrotizing fasciitis).

Contraindications to Conservative Management

• Signs of systemic sepsis.
• Evidence of extensive cellulitis spreading to the vulva or perineum.
• Failure of conservative antibiotic therapy within 48–72 hours.
• Large, multiloculated abscesses requiring formal surgical marsupialization.

5. Management Strategies

Conservative vs. Surgical

1. Antibiotic Therapy: Empiric treatment should target common urogenital pathogens.
   • Recommended: Ceftriaxone (for Gonorrhea) + Doxycycline (for Chlamydia) + Metronidazole (for anaerobes).
2. I&D (Incision and Drainage): The definitive treatment for a fluctuant abscess. Performed under local anesthesia, the incision should be made on the vaginal side of the gland to minimize the risk of urethral injury.
3. Marsupialization: For recurrent cases, the edges of the abscess cavity are sutured to the vaginal mucosa to prevent re-closure and subsequent re-abscess formation.

6. Massive FAQ Section

Q1: Is a Skene’s gland abscess the same as a Bartholin’s gland abscess?
A1: No. Bartholin’s glands are located at the 4 and 8 o’clock positions of the vaginal introitus, whereas Skene’s glands are located adjacent to the urethral meatus.

Q2: What is the most common pathogen found in these abscesses?
A2: Escherichia coli is the most common, but sexually transmitted infections like Neisseria gonorrhoeae must always be ruled out in sexually active patients.

Q3: Can I diagnose this with a physical exam alone?
A3: Often, yes. The location and the presence of a tender, fluctuant mass are highly characteristic. However, ultrasound is recommended to confirm the nature of the fluid collection.

Q4: Is surgical drainage always required?
A4: Small, early-stage abscesses may respond to antibiotics and warm sitz baths. However, once a distinct, fluctuant abscess has formed, drainage is usually necessary for resolution.

Q5: What is the risk of a urethrovaginal fistula after surgery?
A5: The risk is low if the incision is kept on the vaginal side. However, it is a known complication, and patients should be counseled on the importance of avoiding the urethral wall during I&D.

Q6: Does this condition affect fertility?
A6: No, Skene’s gland abscesses do not affect fertility or the reproductive organs.

Q7: Why does the abscess keep coming back?
A7: Recurrence is usually due to the duct remaining blocked or the cavity failing to heal from the inside out. Marsupialization is the preferred treatment for recurrent cases.

Q8: Can this be prevented?
A8: Maintaining good perineal hygiene and treating underlying STIs promptly are the most effective preventative measures.

Q9: What is the role of MRI in this diagnosis?
A9: MRI is used when the clinician suspects a urethral diverticulum rather than a simple Skene’s gland abscess. A diverticulum often requires a different surgical approach (excision vs. simple drainage).

Q10: How long is the recovery time after I&D?
A10: Most patients experience significant pain relief within 24–48 hours post-drainage. Full healing of the mucosal site typically occurs within 2–4 weeks.

7. Clinical Summary for Specialists

A Skene’s gland abscess is a manageable condition provided the clinician maintains a high index of suspicion. The key to successful management lies in differentiating the abscess from urethral diverticula and ensuring that drainage is performed with precise anatomical knowledge to preserve the integrity of the urethra.

Summary Table: Diagnostic Differentiation

Final Recommendations for Practice:

1. Always culture: Resistance patterns are changing; do not rely on empiric therapy alone if the abscess is large.
2. Avoid the midline: When performing I&D, keep the incision strictly lateral to the urethra to avoid the urethral sphincter and mucosa.
3. Follow up: Ensure the patient returns for a post-procedural check to verify that the gland has not re-accumulated fluid.
4. STI Screening: Always offer a full STI panel, as these infections are a significant risk factor for Skene’s gland involvement.

This concludes the clinical guide. For further reading, clinicians are encouraged to consult current ACOG (American College of Obstetricians and Gynecologists) guidelines regarding periurethral pathology and infection management.